InflaRx NV (IFRX)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
May 17, 16:00
1.61
0.00 (0.00%)
After-Hours: 19:30
InflaRx Revenue (Quarterly): 0.0391M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.0391M |
December 31, 2023 | 0.0025M |
Date | Value |
---|---|
September 30, 2023 | 0.0662M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0025M
Minimum
Dec 2023
0.0662M
Maximum
Sep 2023
0.0359M
Average
0.0391M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
Affimed NV | 0.4448M |
MorphoSys AG | 63.62M |
BioNTech SE | 203.77M |
Immatics NV | 32.88M |
CureVac NV | 24.30M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -10.49M |
Total Expenses (Quarterly) | 13.60M |
EPS Diluted (Quarterly) | -0.1847 |
Enterprise Value | -5.240M |
Gross Profit Margin (Quarterly) | -511.9% |
Profit Margin (Quarterly) | -26.80K% |
Earnings Yield | -48.47% |